DNA share

DNA listed its shares on Nasdaq Helsinki (the Helsinki Stock Exchange) towards the end of 2016. DNA’s shares were delisted from Nasdaq Helsinki on 3 February 2020.

Share capital history

DNA listed its shares on Nasdaq Helsinki (the Helsinki Stock Exchange) towards the end of 2016. DNA’s shares were delisted from Nasdaq Helsinki on 3 February 2020. 

DNA has one series of shares and each share entitles to one vote. DNA’s fully paid-up share capital is EUR 72,702,225.65 and the company has 132,303,500 shares.

The following table summarizes the history of DNA’s share capital:

  Number of shares outstanding Number of treasury shares Total number of shares Registered
1 Jan 2013 8,478,532 1,132,144 9,610,676  
31 Dec 2013 8,478,532 1,132,144 9,610,676  
Directed share issue 601   601 11 July 2014
31 Dec 2014 8,479,133 1,132,144 9,611,277  
Directed share issue 605   605 2 Jan 2015
Share subscription under the share based compensation plan 6,475   6,475 15 Jan 2015
Transfer of treasury shares as a part of remuneration 1,657 (1,657) 0  
31 December 2015 8,487,870 1,130,487 9,618,357  
Transer of treasury shares as a part of remuneration 520 (520) 0  
Cancellation of treasury shares   (1,129,967) (1,129,967) 13 Oct 2016
Subdivision of shares (split) through share issue without payment 118,837,460   118,837,460 27 Oct 2016
27 Oct 2016 127,325,850 0 127,325,850  
30 Nov 2016 132,031,957 0 132,031,957  
16 Dec 2016
New shares subscribed for in the personnel offering were registered in the Trade Register
132,303,500 0 132,303,500 16 Dec 2016
1 Jun 2017
Share buyback programme started
  0    
14 Sep 2017
Share buyback programme ended
  967,897    
4 Dec 2017
Transer of treasury shares as a part of remuneration
  -703,080    
  132,303,500 264,817   4 Dec 2017

1 March 2018
Transfer of treasury shares as a part of remuneration

  -82,028    
  132,303,500 182,789   1 March 2018

1 March 2019
Transfer of treasury shares as a part of remuneration

  -61,473    
  132,303,500 121,316   1 March 2019